Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

New data reported from proof-of-principle phase I trial of virosome-based HIV vaccine

Sep. 27, 2011

Gilead Sciences announces CHMP's opinion on Eviplera

Sep. 27, 2011

Phase I data on Ad26.ENVA.01 in HAdV-26-seronegative and -seropositive HIV-1-uninfected adults

Sep. 23, 2011

New phase I data disclosed on Pennvax-B HIV vaccine plus Genevax-IL12

Sep. 22, 2011

Japan Tobacco presents novel HIV integrase inhibitors

Sep. 21, 2011

Second pivotal phase III Quad study meets primary endpoint

Sep. 21, 2011

Inovio reports interim data from global HIV vaccine study

Sep. 13, 2011

GeoVax Labs' HIV/AIDS vaccine development program receives NIAID grant boost

Sep. 6, 2011

Marketing authorization filed for tesamorelin in Argentina

Sep. 5, 2011

Sanofi affiliate files MAA for tesamorelin in Brazil

Sep. 2, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...